Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites
Zhang, Y ; Sun, X ; Muraoka, K ; Ikeda, A ; Miyamoto, S ; Shimizu, H ; Yoshioka, K ; Yamamoto, K
The Journal of biological chemistry, 03 December 1999, Vol.274(49), pp.34657-62 [Periódico revisado por pares]Texto completo disponível